EUVIMEDEUVIMED entdecken
Crossref

Dihydroartemisinin-Loaded ZIF-8 Nanoparticles Elicit Chemo-Immunotherapy against Malignant Pleural Effusion via Inhibition of OCT4/M-CSF Signaling Pathway

Hui You, Liu-Gen Li, Chuan-Yong Xiao, Xiao Wang, Cunqing Kong, Fan Leng, Xiao-Feng Bai, Ning Han, Tong-Fei Li iD, Mei-Fang Wang

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 3131-3145

DOI: 10.1021/acs.molpharmaceut.5c01941 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 22.04.2026. Verfasst von Hui You und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Shiyan Key Laboratory of Major Chronic Respiratory Disease, Taihe Hospital, Hubei University of M…. Hauptthemen laut MEDLINE: Artemisinins, Imidazoles, Pleural Effusion, Malignant, Nanoparticles. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Hubei University of Medicine, Natural Science Foundation of Hubei Province, Hubei Provincial Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArtemisininsImidazolesPleural Effusion, MalignantNanoparticlesAnimalsHumansMiceSignal TransductionCell Line, TumorLung NeoplasmsImmunotherapyFemaleZeolitesMetal-Organic Frameworks

Stichwörter der Autor:innen

M1 polarizationOCT4/NF-κB/M-CSF signalingdihydroartemisinin (DHA)lung cancermalignant pleural effusion (MPE)zeolite imidazole framework-8 (ZIF-8)

Substanzen

ArtemisininsartenimolImidazolesZIF-8 metal-organic frameworkZeolitesMetal-Organic Frameworks

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Shiyan Key Laboratory of Major Chronic Respiratory Disease, Taihe Hospital, Hubei University of Medicine, Renmin Road No. 30, Shiyan, Hubei 442000, China.
  • Shiyan Key Laboratory of Natural Medicine Nanoformulation Research, Hubei Key Laboratory of Embryonic Stem Cell Research, School of Basic Medical Sciences, Hubei University of Medicine, Renmin Road No. 30, Shiyan, Hubei…

ORCID-Profile: Tong-Fei Li

Förderung

  • Hubei University of Medicine
  • Natural Science Foundation of Hubei Province
  • Hubei Provincial Department of Education
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

You, H., Li, L. G., Xiao, C. Y., Wang, X., Kong, C., Leng, F., Bai, X. F., Han, N., Li, T. F., & Wang, M. F. (2026). Dihydroartemisinin-Loaded ZIF-8 Nanoparticles Elicit Chemo-Immunotherapy against Malignant Pleural Effusion via Inhibition of OCT4/M-CSF Signaling Pathway. Molecular Pharmaceutics, 23(5), 3131-3145. https://doi.org/10.1021/acs.molpharmaceut.5c01941

Vancouver

You H, Li LG, Xiao CY, Wang X, Kong C, Leng F, et al. Dihydroartemisinin-Loaded ZIF-8 Nanoparticles Elicit Chemo-Immunotherapy against Malignant Pleural Effusion via Inhibition of OCT4/M-CSF Signaling Pathway. Molecular Pharmaceutics. 2026;23(5):3131-3145. doi:10.1021/acs.molpharmaceut.5c01941

BibTeX
@article{You2026,
  author = {You, Hui and Li, Liu-Gen and Xiao, Chuan-Yong and Wang, Xiao and Kong, Cunqing and Leng, Fan and Bai, Xiao-Feng and Han, Ning and Li, Tong-Fei and Wang, Mei-Fang},
  title = {Dihydroartemisinin-Loaded ZIF-8 Nanoparticles Elicit Chemo-Immunotherapy against Malignant Pleural Effusion via Inhibition of OCT4/M-CSF Signaling Pathway},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {3131--3145},
  doi = {10.1021/acs.molpharmaceut.5c01941}
}
Kostenlos starten →